Farletuzumab-MMAE
Farletuzumab-MMAE

Western blot analysis of beta actin in COS7, Jurkat, C6 and 3T3 lysates using beta actin antibody (1:5000 diluted).

Farletuzumab-MMAE
Cat：
GS90020
Type：
Antibody
Immunogen：
FRA
Reactivity：
Human
Applications：
Reference Antibody
Price：
＄
Farletuzumab-MMAE-GS90020
Data Sheet
MSDS
  • Product details
Product Name
Farletuzumab-MMAE
Cat
GS90020
Heavy chain
EVQLVESGGGVVQPGRSLRLSCSASGFTFSGYGLSWVRQAPGKGLEWVAMISSGGSYTYYADSVKGRFAISRDNAKNTLFLQMDSLRPEDTGVYFCARHGDDPAWFAYWGQGTPVTVSS
Light chain
DIQLTQSPSSLSASVGDRVTITCSVSSSISSNNLHWYQQKPGKAPKPWIYGTSNLASGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQWSSYPYMYTFGQGTKVEIK
Isotype
IgG
Host
Humanised
Purity
>95% by SDS-PAGE
Endotoxin
<1.0 EU/μg as determined by LAL method
Immunogen
FRA
Reactivity
Human
Applications
Reference Antibody
Conjugated
MMAE
Buffer
Preservative:0.01M PBS, PH 7.4
Storage
store at -20°C or -80°C. Avoid repeated freeze.
Type
Antibody
Purposes
For research use only
previous:Trastuzumab MMAEnext:Polatuzumab vedotin-piiq

Related products